Lista de obras - Irina Kiseleva - Dominio Público Uruguay

A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults

artículo científico publicado en 2020

Anti-Influenza Effect of Nanosilver in a Mouse Model

artículo científico publicado en 2020

Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production

artículo científico publicado en 2013

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

artículo científico publicado en 2014

COVID-19 Shuts Doors to Flu but Keeps Them Open to Rhinoviruses

artículo científico publicado en 2021

COVID-19 in Light of Seasonal Respiratory Infections

artículo científico publicado en 2020

Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.

artículo científico publicado en 2004

Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.

artículo científico publicado en 2015

Contribution of neuraminidase of influenza viruses to the sensitivity to sera inhibitors and reassortment efficiency

artículo científico publicado en 2014

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets

artículo científico publicado en 2018

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.

artículo científico publicado en 2016

Development of live cultural pandemic influenza vaccine Vector-Flu

artículo científico publicado en 2011

Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines

artículo científico publicado en 2014

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides

artículo científico publicado en 2016

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

artículo científico publicado en 2019

Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets

artículo científico publicado en 2016

Generation of influenza transfectants using purified recombinant nucleocapsid protein

scientific article published on 01 December 1998

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).

artículo científico publicado en 2011

Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.

artículo científico publicado en 2015

H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

artículo científico publicado en 2015

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

artículo científico publicado en 2015

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses

artículo científico publicado en 2015

Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.

artículo científico publicado en 2006

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models.

artículo científico publicado en 2014

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

artículo científico publicado en 2011

New Points of Departure for More Global Influenza Vaccine Use

artículo científico publicado en 2020

Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research

artículo científico publicado en 2020

Nucleotide sequences of the neuraminidase genes of influenza A/Leningrad/134/57 (H2N2) virus and two of its live, attenuated, cold-adapted variants.

artículo científico publicado en 1995

PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus

article

Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine

artículo científico publicado en 2013

Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

artículo científico publicado en 2004

Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus

artículo científico publicado en 2010

Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains

artículo científico publicado en 2012

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

artículo científico publicado en 2004

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model

artículo científico publicado en 2018

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge

scientific article published on 08 July 2019

Lista de obras de Irina Kiseleva

A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults

Anti-Influenza Effect of Nanosilver in a Mouse Model

Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

COVID-19 Shuts Doors to Flu but Keeps Them Open to Rhinoviruses

COVID-19 in Light of Seasonal Respiratory Infections

Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.

Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.

Contribution of neuraminidase of influenza viruses to the sensitivity to sera inhibitors and reassortment efficiency

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.

Development of live cultural pandemic influenza vaccine Vector-Flu

Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets

Generation of influenza transfectants using purified recombinant nucleocapsid protein

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).

Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.

H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses

Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models.

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

New Points of Departure for More Global Influenza Vaccine Use

Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research

Nucleotide sequences of the neuraminidase genes of influenza A/Leningrad/134/57 (H2N2) virus and two of its live, attenuated, cold-adapted variants.

PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus

Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine

Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus

Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge